Greenspring Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.37M Buy
6,722
+602
+10% +$215K 0.14% 78
2025
Q4
$2M Buy
6,120
+120
+2% +$38.1K 0.12% 83
2025
Q3
$1.69M Buy
+6,000
New +$1.74M 0.3% 25
2025
Q1
$1.87M Hold
6,000
0.44% 19
2024
Q4
$1.56M Sell
6,000
-400
-6% -$119K 0.34% 24
2024
Q3
$2.06M Hold
6,400
0.45% 15
2024
Q2
$2M Hold
6,400
0.48% 14
2024
Q1
$1.82M Hold
6,400
0.45% 16
2023
Q4
$1.84M Hold
6,400
0.51% 15
2023
Q3
$1.72M Hold
6,400
0.54% 14
2023
Q2
$1.42M Sell
6,400
-801
-11% -$186K 0.44% 18
2023
Q1
$1.74M Buy
7,201
+1
+0% +$245 0.38% 32
2022
Q4
$1.89M Hold
7,200
0.5% 23
2022
Q3
$1.62M Buy
7,200
+1
+0% +$242 0.5% 22
2022
Q2
$1.75M Hold
7,199
0.52% 20
2022
Q1
$1.74M Buy
7,199
+59
+0.8% +$13.6K 0.46% 24
2021
Q4
$1.61M Buy
+7,140
New +$1.51M 0.41% 22

Other funds holding AMGN

Greenspring Advisors's AMGN Position: Q1 2026 in Review

Greenspring Advisors increased its Amgen (AMGN) stake by 9.8% in Q1 2026, buying an estimated $215K and bringing the position to 6,722 shares worth $2.37M. The position accounts for 0.14% of the portfolio, ranked #78.

Greenspring Advisors first reported a position in AMGN in Q4 2021 and has held it in 17 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Greenspring Advisors held 6,722 shares of Amgen worth $2.37M as of Q1 2026.
  • Greenspring Advisors bought 602 Amgen shares in Q1 2026, an estimated $215K.
  • Amgen made up 0.14% of Greenspring Advisors's portfolio in Q1 2026, its #78 holding.
  • Greenspring Advisors first reported a position in Amgen in Q4 2021 and has held it in 17 quarters since.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Greenspring Advisors's 13F filing for Q1 2026, filed 5 May 2026.